Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL
NCT07334574
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
B-cell Non-Hodgkin's Lymphoma (B-NHL)
Interventions
BIOLOGICAL:
Personalized neoantigen tumor vaccine
Sponsor
Ruijin Hospital
Collaborators
[object Object]